Adolescent drug exposure: A review of evidence for the development of persistent changes in brain function.
Adolescent
Age Factors
Amphetamine
/ adverse effects
Animals
Brain
/ drug effects
Cannabinoids
/ adverse effects
Cocaine
/ adverse effects
Cognition
/ drug effects
Critical Period, Psychological
Dopamine
/ pharmacology
Ethanol
/ adverse effects
Humans
Illicit Drugs
/ adverse effects
Models, Animal
Nicotine
/ adverse effects
Prefrontal Cortex
/ drug effects
Recreational Drug Use
/ trends
Reward
Adolescence
Alcohol
Amphetamines
Brain development
Cannabinoids
Cocaine
Nicotine
Opioids
Journal
Brain research bulletin
ISSN: 1873-2747
Titre abrégé: Brain Res Bull
Pays: United States
ID NLM: 7605818
Informations de publication
Date de publication:
03 2020
03 2020
Historique:
received:
07
11
2019
revised:
28
12
2019
accepted:
06
01
2020
pubmed:
12
1
2020
medline:
21
8
2021
entrez:
12
1
2020
Statut:
ppublish
Résumé
Over the past decade, many studies have indicated that adolescence is a critical period of brain development and maturation. The refinement and maturation of the central nervous system over this prolonged period, however, makes the adolescent brain highly susceptible to perturbations from acute and chronic drug exposure. Here we review the preclinical literature addressing the long-term consequences of adolescent exposure to common recreational drugs and drugs-of-abuse. These studies on adolescent exposure to alcohol, nicotine, opioids, cannabinoids and psychostimulant drugs, such as cocaine and amphetamine, reveal a variety of long-lasting behavioral and neurobiological consequences. These agents can affect development of the prefrontal cortex and mesolimbic dopamine pathways and modify the reward systems, socio-emotional processing and cognition. Other consequences include disruption in working memory, anxiety disorders and an increased risk of subsequent drug abuse in adult life. Although preventive and control policies are a valuable approach to reduce the detrimental effects of drugs-of-abuse on the adolescent brain, a more profound understanding of their neurobiological impact can lead to improved strategies for the treatment and attenuation of the detrimental neuropsychiatric sequelae.
Identifiants
pubmed: 31926303
pii: S0361-9230(19)30880-9
doi: 10.1016/j.brainresbull.2020.01.007
pii:
doi:
Substances chimiques
Cannabinoids
0
Illicit Drugs
0
Ethanol
3K9958V90M
Nicotine
6M3C89ZY6R
Amphetamine
CK833KGX7E
Cocaine
I5Y540LHVR
Dopamine
VTD58H1Z2X
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
105-117Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest All authors approve this manuscript and declare no conflict of interest related to this work.